Skip to Content

10,462 Results Found

  • Article
  • Open Access
128 Views
13 Pages

28 October 2026

Background/Objectives: Most patients with chronic lymphocytic leukemia (CLL) are diagnosed at an early stage, but the time to first treatment (TTFT) varies widely. We aimed to identify clinical and routine laboratory factors associated with TTFT. Met...

(This article belongs to the Special Issue Diagnosis and Prognosis of Hematological Disease)
  • Article
  • Open Access
3 Citations
3,999 Views
19 Pages

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study

  • Ennio Nano,
  • Francesco Reggiani,
  • Adriana Agnese Amaro,
  • Paola Monti and ,
  • Monica Colombo,
  • Nadia Bertola,
  • Fabiana Ferrero,
  • Franco Fais,
  • Antonella Bruzzese and
  • Giovanna Cutrona
  • + 19 authors+ 14 authors

A “watch and wait” strategy, delaying treatment until active disease manifests, is adopted for most CLL cases; however, prognostic models incorporating biomarkers have shown to be useful to predict treatment requirement. In our prospectiv...

  • Article
  • Open Access
11 Citations
4,310 Views
13 Pages

28 February 2020

The aim of this study was to analyze factors affecting treatment times in patients treated with the surgery-first approach (SFA) for orthognathic surgery. Fifty skeletal class III patients who had undergone SFA bimaxillary orthognathic surgery were e...

(This article belongs to the Special Issue Advances in Digital Dentistry: From Data Acquisition to Data Production)
  • Article
  • Open Access
2 Citations
2,241 Views
17 Pages

Optical Genome Mapping Enhances Structural Variant Detection and Refines Risk Stratification in Chronic Lymphocytic Leukemia

  • Soma Roy Chakraborty,
  • Michelle A. Bickford,
  • Narcisa A. Smuliac,
  • Kyle A. Tonseth and ,
  • Jing Bao,
  • Farzana Murad,
  • Irma G. Domínguez Vigil,
  • Heather B. Steinmetz,
  • Lauren M. Wainman and
  • Wahab A. Khan
  • + 13 authors+ 8 authors

19 January 2026

Background: Optical genome mapping (OGM) detects genome-wide structural variants (SVs), including balanced rearrangements and complex copy-number alterations beyond standard-of-care cytogenomic assays. In chronic lymphocytic leukemia (CLL), cytogenet...

(This article belongs to the Special Issue Cytogenetics and Cytogenomics in Clinical Diagnostics: Innovations and Applications)
  • Article
  • Open Access
1 Citations
2,715 Views
8 Pages

Impact of Time-to-Treatment Initiation and First Inter-Cycle Delay in Patients with Hodgkin Lymphoma

  • Deniz Donmez,
  • Yasemin Evlendi,
  • Taha Koray Sahin,
  • Ibrahim Barista and
  • Serkan Akin

10 June 2025

Background: Delays in treatments are frequent in real-world lymphoma management. This study evaluates the impact of diagnosis-to-treatment intervals (DTIs) and first inter-cycle delay (IcD) on outcomes in patients with Hodgkin lymphoma (HL) receiving...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
9 Citations
4,332 Views
10 Pages

Treatment Resistance: A Time-Based Approach for Early Identification in First Episode Psychosis

  • Kara Dempster,
  • Annie Li,
  • Priyadharshini Sabesan,
  • Ross Norman and
  • Lena Palaniyappan

24 July 2021

Although approximately 1/3 of individuals with schizophrenia are Treatment Resistant (TR), identifying these subjects prospectively remains challenging. The Treatment Response and Resistance in Psychosis working group defines <20% improvement as a...

  • Article
  • Open Access
6 Citations
2,346 Views
12 Pages

Clinical Benefit of First-Pass Recanalization Is Time-Dependent in Endovascular Treatment of Acute Ischemic Stroke

  • Jang-Hyun Baek,
  • Ji Hoe Heo,
  • Hyo Suk Nam,
  • Byung Moon Kim and ,
  • Dong Joon Kim and
  • Young Dae Kim
  • + 1 author+ 0 author

18 October 2023

Clinical benefit can be time-dependent even after first-pass recanalization (FPR) in endovascular treatment of acute stroke. This study aimed to evaluate the association between favorable outcome and FPR under a specific time frame. Patients who unde...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
3 Citations
2,201 Views
16 Pages

15 April 2025

Accurate prognosis at first treatment for bovine respiratory disease (BRD) is essential for timely interventions and management decisions. This cross-sectional observational study evaluated 819 commercial beef feedyard cattle at chute-side for first...

(This article belongs to the Section Veterinary Internal Medicine)
  • Brief Report
  • Open Access
35 Citations
4,420 Views
11 Pages

Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries

  • Swathi Kaliki,
  • Xunda Ji,
  • Yihua Zou,
  • Riffat Rashid and ,
  • Sadia Sultana,
  • Sadik Taju Sherief,
  • Nathalie Cassoux,
  • Rosdali Y. Diaz Coronado,
  • Juan Luis Garcia Leon and
  • Ido Didi Fabian
  • + 29 authors+ 24 authors

19 April 2021

Background: The relationship between lag time and outcomes in retinoblastoma (RB) is unclear. In this study, we aimed to study the effect of lag time between onset of symptoms and diagnosis of retinoblastoma (RB) in countries based on their national-...

(This article belongs to the Special Issue Detection and Treatment of Retinoblastoma)
  • Reply
  • Open Access
137 Views
3 Pages

20 October 2026

We thank Karabuga and Kaya for their Comment on our nationwide C-CAT registry analysis of facility-level medical oncology specialist availability and first-line time to treatment failure (TTF) in lung cancer. We agree that the heterogeneous compositi...

  • Article
  • Open Access
4 Citations
4,034 Views
15 Pages

Kinetic Analysis of the Color of Larch Sapwood and Heartwood during Heat Treatment

  • Yanxia Wei,
  • Peng Zhang,
  • Yang Liu,
  • Yao Chen and ,
  • Jianmin Gao and
  • Yongming Fan
  • + 1 author+ 0 author

24 May 2018

The kinetics of color changes in larch sapwood and heartwood during heat treatment were investigated in this study in order to determine if the process of color change that occurs in the surface of wood can be regulated. Wood samples were heated at 9...

(This article belongs to the Section Forest Ecophysiology and Biology)
  • Article
  • Open Access
861 Views
12 Pages

Pure Nodal Small Lymphocytic Lymphoma: Clinical, Pathologic, and Outcome Features in a Single-Center Cohort

  • Andreea Georgiana Stoica,
  • Mariana Așchie,
  • Miruna Gherase-Cristian,
  • Anca Florentina Mitroi and ,
  • Georgeta Camelia Cozaru,
  • Mădălina Boșoteanu,
  • Cristina Cioti,
  • Sorin Deacu and
  • Irina Tica
  • + 4 authors+ 0 author

22 June 2026

Background and Objectives: Small lymphocytic lymphoma (SLL) represents the tissue-based manifestation of chronic lymphocytic leukemia (CLL). Despite their shared biological background, patients with SLL have been underrepresented in CLL-focused clini...

(This article belongs to the Section Hematology and Immunology)
  • Article
  • Open Access
2 Citations
652 Views
16 Pages

Japan’s Center for Cancer Genomics and Advanced Therapeutics (C-CAT) provides a national platform for studying genomic-medicine-era care. We conducted a nationwide registry/database study to examine whether facility-level Japanese Society of Me...

(This article belongs to the Section Thoracic Oncology)
  • Article
  • Open Access
27 Citations
8,278 Views
14 Pages

Real-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data

  • Vamsidhar Velcheti,
  • Xiaohan Hu,
  • Yeran Li,
  • Hazem El-Osta and ,
  • M. Catherine Pietanza and
  • Thomas Burke
  • + 1 author+ 0 author

18 February 2022

Our aim was to evaluate real-world time on treatment (rwToT), overall and by KRAS mutation status, with first-line pembrolizumab monotherapy for advanced non-small cell lung cancer (NSCLC) in real-world oncology practice in the US. rwToT is a readily...

(This article belongs to the Special Issue Immunotherapy for Non-small Cell Lung Cancer)
  • Comment
  • Open Access
1 Citations
135 Views
3 Pages

20 October 2026

Time to treatment failure (TTF) is a pragmatic endpoint that captures treatment discontinuation for multiple reasons. In a recent nationwide C-CAT registry analysis, Kajiura et al. examined whether facility-level medical oncology specialist availabil...

(This article belongs to the Section Palliative and Supportive Care)
  • Article
  • Open Access
34 Citations
5,137 Views
15 Pages

Convection-Enhanced Delivery of a First-in-Class Anti-β1 Integrin Antibody for the Treatment of High-Grade Glioma Utilizing Real-Time Imaging

  • Chibueze D. Nwagwu,
  • Amanda V. Immidisetti,
  • Gabriela Bukanowska,
  • Michael A. Vogelbaum and
  • Anne-Marie Carbonell

Introduction: OS2966 is a first-in-class, humanized and de-immunized monoclonal antibody which targets the adhesion receptor subunit, CD29/β1 integrin. CD29 expression is highly upregulated in glioblastoma and has been shown to drive tumor progr...

(This article belongs to the Special Issue Drug Delivery to Brain Tumors)
  • Article
  • Open Access
18 Citations
7,645 Views
13 Pages

Fecundability, the probability of conception in a month or in a menstrual cycle, varies across and within age groups for both women and men. Fertility treatment has become common in a number of countries including Japan, but its impact on the age pat...

(This article belongs to the Special Issue The Environment and Reproductive Health: Feature Papers)
  • Article
  • Open Access
580 Views
12 Pages

Effects of First Time Minimum Volume Regulation on the Surgical Treatment of Lung Cancer in Germany

  • Julia Riedel,
  • Michael Ried,
  • Erich Hecker,
  • Stephan Eggeling and ,
  • Martin Utzig and
  • Hans-Stefan Hofmann
  • + 1 author+ 0 author

9 June 2026

Objectives: In 2021, the German Federal Joint Committee (G-BA) introduced minimum volume regulations (MVRs) for the surgical treatment of lung cancer with the aim of improving quality of care through centralization. The present study aimed to evaluat...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
2 Citations
1,265 Views
11 Pages

Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia

  • Priyatharsini Nirmalanantham,
  • Andrés E. Quesada,
  • Anindita Ghosh,
  • Pei Lin and ,
  • Chi Y. Ok,
  • Richard K. Yang,
  • Hong Fang,
  • Sofia Garces,
  • Rashmi Kanagal-Shamanna and
  • Fatima Zahra Jelloul
  • + 19 authors+ 14 authors

6 November 2025

Background/Objectives: NOTCH1 is frequently mutated in chronic lymphocytic leukemia (CLL) and is a marker of poor prognosis. In addition to NOTCH1, mutations in the NOTCH1 regulatory pathway including SPEN have been described in a limited number of C...

(This article belongs to the Special Issue Advances in Pathology of Lymphoma and Leukemia)
  • Article
  • Open Access
9 Citations
3,147 Views
15 Pages

Changes in Sexuality and Sexual Dysfunction over Time in the First Two Years after Treatment of Head and Neck Cancer

  • Margot A. Stone,
  • Birgit I. Lissenberg-Witte,
  • Remco de Bree,
  • Jose A. Hardillo and ,
  • Femke Lamers,
  • Johannes A. Langendijk,
  • C. René Leemans,
  • Robert P. Takes,
  • Femke Jansen and
  • Irma M. Verdonck-de Leeuw
  • + 5 authors+ 0 author

27 September 2023

The aim of this study was to investigate changes in sexuality and sexual dysfunction in head and neck cancer (HNC) patients in the first two years after treatment, in relation to the type of treatment. Data were used of 588 HNC patients participating...

(This article belongs to the Special Issue 2nd Edition: Targeting Head and Neck Cancer)
  • Article
  • Open Access
6 Citations
4,950 Views
14 Pages

Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study

  • Sneha Sura,
  • Manojkumar Bupathi,
  • Valerie Morris,
  • Paul Conkling and ,
  • Karen Todoroff,
  • Abhijeet Bhanegaonkar and
  • Chiemeka Ike
  • + 2 authors+ 0 author

Avelumab first-line maintenance (1LM) is approved for patients with locally advanced or metastatic urothelial carcinoma (la/mUC) who do not have disease progression after platinum-based chemotherapy (PBC). This retrospective study describes real-worl...

(This article belongs to the Section Genitourinary Oncology)
  • Article
  • Open Access
4 Citations
2,212 Views
18 Pages

22 February 2025

Anaerobic digestion is a common method for treating sewage sludge in municipal wastewater treatment plants (WWTPs). However, modelling this process can be very challenging due to the complexity of biochemical reactions. This paper presents a novel me...

(This article belongs to the Special Issue Energy from Agricultural and Forestry Biomass Waste)
  • Article
  • Open Access
25 Citations
6,310 Views
12 Pages

Quality of Life in Breast Cancer Survivors in Relation to Age, Type of Surgery and Length of Time since First Treatment

  • Sergio Alvarez-Pardo,
  • Ena Monserrat Romero-Pérez,
  • Néstor Camberos-Castañeda,
  • José Antonio de Paz and ,
  • Mario Alberto Horta-Gim,
  • Jerónimo J. González-Bernal,
  • Juan Mielgo-Ayuso,
  • Lucía Simón-Vicente,
  • Jessica Fernández-Solana and
  • Josefa González-Santos
  • + 5 authors+ 0 author

(1) Background: Quality of life assessment is a critical aspect of breast cancer patient outcomes, as diagnosis, prognosis and treatment can have a major impact on quality of life. The aim of this study was to describe the characteristics of the samp...

(This article belongs to the Special Issue Promoting Health and Well-Being in Individual, Families, and Communities)
  • Article
  • Open Access
9 Citations
3,451 Views
12 Pages

Evaluation of First Treatment Timing, Fatal Disease Onset, and Days from First Treatment to Death Associated with Bovine Respiratory Disease in Feedlot Cattle

  • Kristen J. Smith,
  • Brad J. White,
  • David E. Amrine,
  • Robert L. Larson and ,
  • Miles E. Theurer,
  • Josh I. Szasz,
  • Tony C. Bryant and
  • Justin W. Waggoner
  • + 3 authors+ 0 author

8 March 2023

Bovine respiratory disease (BRD) is a frequent beef cattle syndrome. Improved understanding of the timing of BRD events, including subsequent deleterious outcomes, promotes efficient resource allocation. This study’s objective was to determine...

(This article belongs to the Section Veterinary Microbiology, Parasitology and Immunology)
  • Article
  • Open Access
1 Citations
1,647 Views
9 Pages

Lung Carcinoids—Time to Change Practices

  • Ana Rodrigues,
  • Nuno Coimbra,
  • Inês Lucena Sampaio,
  • Isabel Azevedo and ,
  • Marta Soares,
  • Carmen Jerónimo and
  • Rui Henrique
  • + 2 authors+ 0 author

Background: Lung carcinoids—typical and atypical—are rare neuroendocrine tumors (NETs) representing 1–2% of lung cancers. Despite clinicopathological differences, their clinical management often mirrors lung cancer protocols rather...

(This article belongs to the Section Thoracic Oncology)
  • Article
  • Open Access
7 Citations
7,743 Views
14 Pages

What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study

  • Giovanni D’Arena,
  • Candida Vitale,
  • Giuseppe Pietrantuono,
  • Oreste Villani and ,
  • Giovanna Mansueto,
  • Fiorella D’Auria,
  • Teodora Statuto,
  • Simona D’Agostino,
  • Rosalaura Sabetta and
  • Luca Laurenti
  • + 13 authors+ 8 authors

22 January 2024

Atypical chronic lymphocytic leukemia (CLL) is still defined according to morphological criteria. However, deviance from the typical surface immunological profile suggests an atypical immunological-based CLL. A large cohort of patients with CLL was r...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
7 Citations
3,966 Views
10 Pages

CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia

  • Giovanni D’Arena,
  • Candida Vitale,
  • Marta Coscia,
  • Daniela Lamorte and ,
  • Giuseppe Pietrantuono,
  • Francesca Perutelli,
  • Fiorella D’Auria,
  • Teodora Statuto,
  • Luciana Valvano and
  • Luca Laurenti
  • + 17 authors+ 12 authors

23 August 2021

Membrane-bound CD200 is overexpressed in chronic lymphocytic leukemia (CLL), and there is some evidence that its soluble ectodomain (sCD200) could also be involved in the pathophysiology and the disease. However, very little is known about sCD200’s p...

(This article belongs to the Special Issue Therapeutic Targets in Chronic Lymphocytic Leukemia)
  • Article
  • Open Access
14 Citations
1,061 Views
7 Pages

Radiation Treatment Waiting Times for Breast Cancer Patients in Manitoba, 2001 and 2005

  • A. L. Cooke,
  • R. Appell,
  • K. Suderman,
  • K. Fradette and
  • S. Latosinsky

1 September 2009

Introduction: Our study examined the wait time from ready-to-treat to radiation therapy for cohorts of breast cancer patients requiring adjuvant radiation therapy in 2001 and in 2005 after the implementation of strategies to reduce wait times for rad...

  • Article
  • Open Access
1,489 Views
16 Pages

14 October 2024

This article presents the results of deformation characteristics and crack stress thresholds of cement stone under different acid treatment times. A series of true triaxial tests were conducted on cement stones under four sulfuric acid treatment time...

  • Article
  • Open Access
3 Citations
3,980 Views
12 Pages

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape

  • Christian Doehn,
  • Martin Bögemann,
  • Viktor Grünwald,
  • Manfred Welslau and ,
  • Jens Bedke,
  • Martin Schostak,
  • Thomas Wolf,
  • Rainer Ehneß,
  • Elisa Degenkolbe and
  • Peter J. Goebell
  • + 6 authors+ 1 author

8 November 2022

The approval of tyrosine kinase inhibitors and checkpoint inhibitors represented a remarkable progression in the therapeutic landscape for the treatment of metastatic renal cell carcinoma (mRCC). Yet, in the ever-evolving landscape of mRCC treatment,...

(This article belongs to the Special Issue Urological Cancer 2022)
  • Article
  • Open Access
4 Citations
4,424 Views
21 Pages

Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001

  • Filippo De Braud,
  • Barbara Deschler-Baier,
  • John C. Morris,
  • Francis Worden and ,
  • Yimei Han,
  • Urpo Kiiskinen,
  • Min-Hua Jen,
  • Scott S. Barker,
  • Sylwia Szymczak and
  • Adrienne M. Gilligan
  • + 5 authors+ 0 author

27 December 2023

Selpercatinib is indicated for locally advanced/metastatic RET-activated solid tumors after progression or following prior systemic therapies. Until the recently published data from LIBRETTO-431 and LIBRETTO-531, there were limited effectiveness data...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
22 Citations
4,787 Views
22 Pages

The Effect of DBD Plasma Activation Time on the Dyeability of Woven Polyester Fabric with Disperse Dye

  • Thu Nguyen Thi Kim,
  • Khanh Vu Thi Hong,
  • Nguyen Vu Thi and
  • Hai Vu Manh

29 April 2021

This study consists of two parts. In the first, the woven polyester fabric, after washing to remove lubricant oils, was treated with the dielectric barrier discharge (DBD) plasma at the short plasma exposure time (from 15 to 90 s). The effect of the...

(This article belongs to the Special Issue Plasma Processing of Polymers)
  • Review
  • Open Access
15 Citations
10,795 Views
13 Pages

EML4-ALK: Update on ALK Inhibitors

  • Alessandra Bearz,
  • Elisa Bertoli,
  • Brigida Stanzione,
  • Elisa De Carlo and ,
  • Alessandro Del Conte,
  • Martina Bortolot,
  • Sara Torresan,
  • Eleonora Berto,
  • Valentina Da Ros and
  • Michele Spina
  • + 8 authors+ 3 authors

Since the discovery of the first-generation ALK inhibitor, many other tyrosine kinase inhibitors have been demonstrated to be effective in the first line or further lines of treatment in patients with advanced non-small cell lung cancer with EMLA4-AL...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
5 Citations
3,696 Views
15 Pages

Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse

  • Peng Du,
  • Hongyi Chen,
  • Li Shen,
  • Xiao Liu and ,
  • Xuefan Wu,
  • Lang Chen,
  • Aihong Cao and
  • Daoying Geng
  • + 3 authors+ 0 author

17 September 2022

Background: Primary central nervous system lymphoma (PCNSL) is a rare extranodal non-Hodgkin’s lymphoma that occurs in the central nervous system. Although sensitive to chemotherapy, 35–60% of PCNSL patients still relapse within 2 years a...

(This article belongs to the Section Neuro-Oncology)
  • Article
  • Open Access
13 Citations
1,122 Views
8 Pages

Quantifying Treatment Delays in Adolescents and Young Adults with Cancer at McGill University

  • Y. Xu,
  • M. Stavrides-Eid,
  • A. Baig,
  • M. Cardoso and ,
  • Y.S. Rho,
  • W.M. Shams,
  • A. Mamo and
  • P. Kavan
  • + 3 authors+ 0 author

1 December 2015

Background: Since the end of the 1980s, the magnitude of survival prolongation or mortality reduction has not been the same for adolescents and young adults (ayas) with cancer as for their older and younger counterparts. Precise reasons for those obs...

  • Article
  • Open Access
8 Citations
3,081 Views
18 Pages

The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study

  • Anne-Marie Garrett,
  • Sarah Lastakchi and
  • Christopher McConville

6 February 2020

The molecular heterogeneity of glioblastoma has been linked to differences in survival and treatment response, while the development of personalised treatments may be a novel way of combatting this disease. Here we show for the first time that low pa...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
2 Citations
3,220 Views
13 Pages

Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer—A Nationwide Cohort Study

  • Maria D’Souza,
  • Mette Bagger,
  • Mark Alberti,
  • Morten Malmborg and ,
  • Morten Schou,
  • Christian Torp-Pedersen,
  • Gunnar Gislason,
  • Inge Marie Svane and
  • Jens Folke Kiilgaard
  • + 4 authors+ 0 author

23 December 2021

Purpose: To estimate the frequency of first-time ocular events in patients treated with immune checkpoint inhibitors (ICI). Methods: Patients with cancer in 2011–2018 in Denmark were included and followed. The outcomes were first-time ophthalmo...

(This article belongs to the Special Issue Epidemiology and Biological Features of Melanoma)
  • Article
  • Open Access
680 Views
16 Pages

Objectives: This study aimed to evaluate and compare the cost-effectiveness of the surgery-first and orthodontic-first approaches in Thai patients with dentofacial deformities undergoing orthognathic surgery. Methods: This retrospective cohort study...

(This article belongs to the Section Healthcare Quality, Patient Safety, and Self-care Management)
  • Article
  • Open Access
30 Citations
4,966 Views
15 Pages

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients

  • Markus Kieler,
  • Matthias Unseld,
  • Daniela Bianconi,
  • Martin Schindl and ,
  • Gabriela V. Kornek,
  • Werner Scheithauer and
  • Gerald W. Prager
  • + 2 authors+ 0 author

28 February 2020

Background: New chemotherapy regimens for the treatment of metastatic pancreatic cancer have changed the therapy paradigm. We aimed to assess their impact on the treatment landscape and clinical outcome at our academic institution. Methods: In this s...

(This article belongs to the Section Oncology)
  • Review
  • Open Access
17 Citations
6,798 Views
13 Pages

Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer

  • Brigida Stanzione,
  • Alessandro Del Conte,
  • Elisa Bertoli,
  • Elisa De Carlo and ,
  • Alberto Revelant,
  • Michele Spina and
  • Alessandra Bearz
  • + 2 authors+ 0 author

ROS proto-oncogene 1 (ROS1) rearrangements occur in 0.9–2.6% of patients with non small cell lung cancer (NSCLC), conferring sensitivity to treatment with specific tyrosine-kinase inhibitors (TKI). Crizotinib, a first-generation TKI, was the fi...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
33 Citations
5,199 Views
26 Pages

Chemical Composition and Plant Growth of Centaurea raphanina subsp. mixta Plants Cultivated under Saline Conditions

  • Spyridon A. Petropoulos,
  • Ângela Fernandes,
  • Maria Ines Dias,
  • Carla Pereira and ,
  • Ricardo C. Calhelha,
  • Antonios Chrysargyris,
  • Nikolaos Tzortzakis,
  • Marija Ivanov,
  • Marina D. Sokovic and
  • Isabel C. F. R. Ferreira
  • + 6 authors+ 1 author

The aim of this report was to study the effect of salinity (control: 2dS/m, S1: 4 dS/m and S2: 6 dS/m) and harvest time (first harvest on 9 May 2018 and second harvest on 19 April 2018) on the growth and the chemical composition of Centaurea raphanin...

(This article belongs to the Collection Qualitative and Quantitative Analysis of Bioactive Natural Products)
  • Article
  • Open Access
2,062 Views
10 Pages

12 October 2023

Background: Patients with endocrine-resistant metastatic breast cancer (MBC) require cytostatic therapy. Single-agent taxanes and anthracyclines, including pegylated liposomal doxorubicin (PLD), are standard treatment options. There are no prospectiv...

(This article belongs to the Special Issue Advances in Invasive Breast Cancer: Treatment and Prognosis)
  • Proceeding Paper
  • Open Access
1,918 Views
10 Pages

First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer

  • Simon Nannini,
  • Fabien Moinard-Butot,
  • Sylvain Ladoire,
  • Dorian Bochaton and ,
  • Pierre Bigot,
  • Félix Lefort,
  • Hakim Mahammedi,
  • Fabien Calcagno,
  • Jean-Baptiste Barbe Richaud and
  • Philippe Barthélémy
  • + 10 authors+ 5 authors

The CABONEXT study is the first multicenter retrospective analysis evaluating subsequent systemic therapies after cabozantinib-based treatment in metastatic renal cell carcinoma (mRCC). This interim analysis includes 77 patients receiving subsequent...

(This article belongs to the Proceedings of The 2025 International Kidney Cancer Symposium)
  • Communication
  • Open Access
2 Citations
3,205 Views
15 Pages

Is Winter Feeder Visitation by Songbirds Risk-Dependent? An Experimental Study

  • Brygida Manikowska-Ślepowrońska and
  • Krzysztof Ślepowroński

17 August 2025

Winter bird feeders provide high-energy food for birds when natural food resources are in short supply. We performed an experimental study including two treatments and a control to investigate the reactions of eight passerine species visiting a winte...

  • Article
  • Open Access
13 Citations
3,016 Views
17 Pages

29 March 2024

To establish the safe and reproducible effects of cold plasma (CP) technology on food products, this study evaluated the gelatinization parameters, fatty acid profile, and hygroscopic properties of rice grains repeatedly treated with low-pressure rad...

(This article belongs to the Special Issue Effect of Processing and Cooking on Physicochemical, Sensory, and Functional Properties of Food)
  • Article
  • Open Access
3 Citations
2,192 Views
16 Pages

Effects of Fuel Removal on the Flammability of Surface Fuels in Betula platyphylla in the Wildland–Urban Interface

  • Xintong Chen,
  • Mingyu Wang,
  • Baozhong Li,
  • Lixuan Wang and ,
  • Jibin Ning,
  • Guang Yang and
  • Hongzhou Yu
  • + 2 authors+ 0 author

22 July 2024

This paper aimed to provide technical support for fuel management by exploring different strengths of fuel removal on the physical and chemical properties and flammability of Betula platyphylla forests in the wildland–urban interface. After inv...

(This article belongs to the Special Issue Forest Fuel Treatment and Fire Risk Assessment)
  • Article
  • Open Access
7 Citations
3,334 Views
14 Pages

A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

  • Chalid Assaf,
  • Timothy M. Illidge,
  • Nathalie Waser,
  • Mary He and ,
  • Tina Li,
  • Athanasios Zomas,
  • Nawal Bent-Ennakhil,
  • Meredith Little,
  • Pablo L. Ortiz-Romero and
  • Martine Bagot
  • + 7 authors+ 2 authors

30 November 2023

(1) Background: Most patients with mycosis fungoides (MF), a form of cutaneous T-cell lymphoma (CTCL), develop relapsed/refractory (R/R) disease following front-line systemic therapy. This report describes treatment patterns and outcomes from the sub...

(This article belongs to the Special Issue Cutaneous Lymphoma)
  • Perspective
  • Open Access
1 Citations
2,870 Views
6 Pages

Case Series: Reactivation of Herpetic Keratitis After COVID-19 mRNA Vaccination During Herpetic Prophylaxis

  • Michael Tsatsos,
  • Efthymia Prousali,
  • Athanasios Karamitsos and
  • Nikolaos Ziakas

28 July 2025

This report presents two cases of herpes simplex keratitis recurrence after COVID-19 mRNA vaccination in patients on herpetic prophylaxis due to recurrent herpetic keratitis. A 58-year-old man with a history of a previous penetrating keratoplasty pre...

  • Article
  • Open Access
11 Citations
4,494 Views
13 Pages

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis

  • Manuela Gizzarelli,
  • Valentina Foglia Manzillo,
  • Antonio Inglese,
  • Serena Montagnaro and
  • Gaetano Oliva

Miltefosine-Allopurinol (MIL-AL) combination is reported to be one of the most effective treatments for canine leishmaniosis, thanks to its oral administration and MIL-documented low impact on renal function. However, MIL-AL is considered a second-ch...

(This article belongs to the Special Issue Leishmaniasis: Transmission, Pathogenesis and Treatment)
  • Article
  • Open Access
4 Citations
3,002 Views
10 Pages

Association between Health-Related Quality of Life and Completion of First-Line Treatment among Lung Cancer Patients

  • Anne Katrine G. Levinsen,
  • Susanne O. Dalton,
  • Ingelise Andersen,
  • Anders Mellemgaard and ,
  • Marianne S. Oksen,
  • Lena Saltbæk,
  • Nina H. G. Hansen,
  • Signe Carlsen and
  • Trille K. Kjaer
  • + 4 authors+ 0 author

9 July 2022

Experts recommend assessing lung cancer patients’ health-related quality of life (HRQOL) in the diagnostic evaluation. We investigated the association between HRQOL and completion of first-line treatment among lung cancer patients in a prospect...

(This article belongs to the Section Cancer Survivorship and Quality of Life)

of 210